Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (22)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reid, D. W.
Right arrow Articles by Kotsimbos, T. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reid, D. W.
Right arrow Articles by Kotsimbos, T. C.
(Chest. 2002;121:48-54.)
© 2002 American College of Chest Physicians

Iron Deficiency in Cystic Fibrosis*

Relationship to Lung Disease Severity and Chronic Pseudomonas aeruginosa Infection

David W. Reid, MD; Nicholas J. Withers, MD; Libby Francis, RN; John W. Wilson, MD, FCCP and Thomas C. Kotsimbos, MD

* From the Cystic Fibrosis Service, Department of Respiratory Medicine, Monash University Medical School, Alfred Hospital, Prahran, Melbourne, VIC, Australia.

Correspondence to: David W. Reid, MD, Cystic Fibrosis Service, Department of Respiratory Medicine, Monash University Medical School, Alfred Hospital, Commercial Rd, Prahran, Melbourne, VIC, Australia 3181; e-mail: d.reid{at}alfred.org.au

Background: Iron deficiency (ID) is common in patients with cystic fibrosis (CF) and may be related to GI factors and chronic inflammation. Pseudomonas aeruginosa (PA) infection is predominantly responsible for chronic lung suppuration in patients with CF, but its survival is critically dependent on the availability of extracellular iron, which it obtains via highly efficient mechanisms.

Objective: To determine whether ID in CF patients is directly related to the severity of suppurative lung disease.

Design: We determined the iron status of 30 randomly selected adult CF patients (13 women) and assessed the relationship to lung disease severity and GI factors by determining their daily sputum volume, FEV1 percent predicted, C-reactive protein (CRP) level, erythrocyte sedimentation rate, and degree of pancreatic supplementation. Additionally, we measured the sputum concentrations of iron and ferritin in a randomly selected subgroup of 13 of the 30 subjects.

Setting: Adult CF Service in a tertiary-care center.

Results: Seventy-four percent of subjects experienced ID (ie, serum iron levels <= 12 µmol/L and/or transferrin saturation levels <= 16%). There was no relationship found with the degree of pancreatic supplementation. The daily sputum volume was strongly associated with low serum iron levels, transferrin saturation, ferritin/CRP ratio, and FEV1 percent predicted (p < 0.05). Serum iron levels and transferrin saturation were negatively related to CRP (r = -0.8 and r = -0.7, respectively; p < 0.01) and erythrocyte sedimentation rate (r = -0.5 and r = -0.4, respectively; p < 0.05). FEV1 percent predicted was positively related to serum iron level (r = 0.5; p < 0.01), transferrin saturation (r = 0.4; p < 0.05), and ferritin/CRP ratio (r = 0.7; p < 0.05). Sputum iron concentration (median, 63 µmol/L; range, 17 to 134 µmol/L) and ferritin concentration (median, 5,038 µg/L; range, 894 to 6,982 µg/L) exceeded plasma levels and negatively correlated with FEV1 percent predicted (r = -0.6 and r = -0.5, respectively; p <= 0.05).

Conclusion: In our CF patients, ID was directly related to the increased severity of suppurative lung disease but not to the degree of pancreatic insufficiency. Iron loss into the airway may contribute to ID and may facilitate PA infection.

Key Words: cystic fibrosis • iron deficiency • Pseudomonas aeruginosa




This article has been cited by other articles:


Home page
J. Bacteriol.Home page
J. B. McPhee, M. Bains, G. Winsor, S. Lewenza, A. Kwasnicka, M. D. Brazas, F. S. L. Brinkman, and R. E. W. Hancock
Contribution of the PhoP-PhoQ and PmrA-PmrB Two-Component Regulatory Systems to Mg2+-Induced Gene Regulation in Pseudomonas aeruginosa
J. Bacteriol., June 1, 2006; 188(11): 3995 - 4006.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
D.W. Reid, Q.T. Lam, H. Schneider, and E.H. Walters
Airway iron and iron-regulatory cytokines in cystic fibrosis
Eur. Respir. J., August 1, 2004; 24(2): 286 - 291.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
D. W. Reid and S. M. Kirov
Iron, Pseudomonas aeruginosa and cystic fibrosis
Microbiology, March 1, 2004; 150(3): 516 - 516.
[Full Text] [PDF]


Home page
MicrobiologyHome page
A.-P. Zeng and E.-J. Kim
Iron availability, oxygen limitation, Pseudomonas aeruginosa and cystic fibrosis
Microbiology, March 1, 2004; 150(3): 516 - 518.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American College of Chest Physicians.